Literature DB >> 16087198

Gestational mutations and carcinogenesis.

Rafael Meza1, E Georg Luebeck, Suresh H Moolgavkar.   

Abstract

We present a mathematical formulation to evaluate the effects of gestational mutations on cancer risk. The hazard or incidence function of cancer is expressed in terms of the Probability Generating Function (PGF) of the number of normal and mutated cells at birth. Using Filtered Poisson Process Theory, we obtain the PGF for several models for the accumulation of gestational mutations. In particular, we develop expressions for the hazard function when one or two successive mutations could occur during gestation. We also calculate the hazard when the background gestational mutation rates are increased due to exposure to mutagens, such as prenatal radiation. To illustrate the use of our models, we apply them to colorectal cancer in the SEER database. We find that the proportion of cancer risk attributable to developmental mutations depends on age and that it could be quite significant when gestational mutation rates are high. The analysis of the SEER data also shows that gestational mutations could contribute to inter-individual variations in colorectal cancer risk.

Entities:  

Mesh:

Year:  2005        PMID: 16087198     DOI: 10.1016/j.mbs.2005.06.003

Source DB:  PubMed          Journal:  Math Biosci        ISSN: 0025-5564            Impact factor:   2.144


  21 in total

1.  Colorectal cancer incidence trends in the United States and United kingdom: evidence of right- to left-sided biological gradients with implications for screening.

Authors:  Rafael Meza; Jihyoun Jeon; Andrew G Renehan; E Georg Luebeck
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

2.  Age-specific incidence of cancer: Phases, transitions, and biological implications.

Authors:  Rafael Meza; Jihyoun Jeon; Suresh H Moolgavkar; E Georg Luebeck
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-20       Impact factor: 11.205

3.  Evaluation of screening strategies for pre-malignant lesions using a biomathematical approach.

Authors:  Jihyoun Jeon; Rafael Meza; Suresh H Moolgavkar; E Georg Luebeck
Journal:  Math Biosci       Date:  2008-02-26       Impact factor: 2.144

Review 4.  Evolution in health and medicine Sackler colloquium: Somatic evolutionary genomics: mutations during development cause highly variable genetic mosaicism with risk of cancer and neurodegeneration.

Authors:  Steven A Frank
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-23       Impact factor: 11.205

5.  Incremental benefits of screening colonoscopy over sigmoidoscopy in average-risk populations: a model-driven analysis.

Authors:  Jihyoun Jeon; Rafael Meza; William D Hazelton; Andrew G Renehan; E Georg Luebeck
Journal:  Cancer Causes Control       Date:  2015-03-18       Impact factor: 2.506

6.  Longitudinal multistage model for lung cancer incidence, mortality, and CT detected indolent and aggressive cancers.

Authors:  William D Hazelton; Gary Goodman; William N Rom; Melvyn Tockman; Mark Thornquist; Suresh Moolgavkar; Joel L Weissfeld; Ziding Feng
Journal:  Math Biosci       Date:  2012-06-15       Impact factor: 2.144

7.  Sporadic colorectal cancer: Studying ways to an end.

Authors:  Isadora Rosa; Paulo Fidalgo; Bruno Filipe; Cristina Albuquerque; Ricardo Fonseca; Paula Chaves; António D Pereira
Journal:  United European Gastroenterol J       Date:  2015-08-06       Impact factor: 4.623

8.  A Systematic Approach to Determining the Identifiability of Multistage Carcinogenesis Models.

Authors:  Andrew F Brouwer; Rafael Meza; Marisa C Eisenberg
Journal:  Risk Anal       Date:  2016-09-09       Impact factor: 4.000

Review 9.  Systems biological and mechanistic modelling of radiation-induced cancer.

Authors:  M P Little; W F Heidenreich; S H Moolgavkar; H Schöllnberger; D C Thomas
Journal:  Radiat Environ Biophys       Date:  2007-12-21       Impact factor: 1.925

10.  Does folic acid supplementation prevent or promote colorectal cancer? Results from model-based predictions.

Authors:  E Georg Luebeck; Suresh H Moolgavkar; Amy Y Liu; Alanna Boynton; Cornelia M Ulrich
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-06-06       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.